Clinical Trials Directory

Trials / Unknown

UnknownNCT03264638

A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS

A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of Polycystic Ovary Syndrome

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
315 (estimated)
Sponsor
Aijun Sun · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effects and biological mechanisms of Dingkundan,Diane-35 and the combination of Dingkundan and Diane-35 in the treatment of polycystic syndrome(PCOS) in adults women. One third of participants will receive Dingkundan capsules, one third of participants will receive Diane-35 Pills, and the another third will receive Dingkundan capsules and Diane-35 in combination.

Detailed description

Dingkundan,Diane-35 each ameliorate PCOS, but they do so by different mechanisms. We generally treat PCOS patients without immediate fertility requirement by short-acting contraceptives,Diane-35 is one of the most commonly used drugs. Dingkundan consists of multiple chinese herbs including ginseng,Panax notoginseng,deer antlers,Carthamus tinctorius L.,Radix Paeoniae Alba,prepared Radix Rehmanniae,Angelica etc., which gains widespread application in the treatment of gynecological diseases. Based on the characteristics above, we try to explore its clinical application value in PCOS and its biological mechanisms.

Conditions

Interventions

TypeNameDescription
DRUGDingkundanDingkundan 7g capsule by mouth, twice daily, beginning on Day 5 of menstrual cycle for 21 consecutive days followed by a 7-day interval without medication; for three cycles
DRUGDingkundan & Diane-35Dingkundan 7g capsule by mouth, twice daily, and Diane-35 one pill by mouth, once daily, beginning on Day 5 of menstrual cycle for 21 consecutive days followed by a 7-day interval without medication; for three cycles
DRUGDiane-35Diane-35 one pill by mouth,once daily, beginning on Day 5 of menstrual cycle for 21 consecutive days followed by a 7-day interval without medication; for three cycles

Timeline

Start date
2016-10-01
Primary completion
2018-08-31
Completion
2018-08-31
First posted
2017-08-29
Last updated
2018-02-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03264638. Inclusion in this directory is not an endorsement.